Literature DB >> 25462000

Bisphosphonate prescriptions in men with androgen deprivation therapy use.

Husayn Gulamhusein1, Lingsong Yun2, Angela M Cheung1, Rinku Sutradhar2, Lawrence Paszat2, Padraig Warde3, Shabbir M H Alibhai1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25462000     DOI： 10.1001/jama.2014.14038

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  Prevention and treatment of bone fragility in cancer patient.

Authors:  Silva Ottanelli
Journal:  Clin Cases Miner Bone Metab       Date:  2015-10-26

2.  Quality of care provided to prostate cancer (PC) patients for prevention and treatment of osteoporosis induced by androgen deprivation therapy (ADT).

Authors:  Rehab Chahin; Husayn Gulamhusein; Henriette Breunis; Shabbir M H Alibhai
Journal:  Support Care Cancer       Date:  2016-07-02       Impact factor: 3.603

3.  Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease: A meta-analysis.

Authors:  Liwei Yao; Haiqing Wang; Wenwei Dong; Zhenxin Liu; Haijiao Mao
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

Review 4.  The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation.

Authors:  Luisella Cianferotti; Francesco Bertoldo; Marco Carini; John A Kanis; Alberto Lapini; Nicola Longo; Giuseppe Martorana; Vincenzo Mirone; Jean-Yves Reginster; Rene Rizzoli; Maria Luisa Brandi
Journal:  Oncotarget       Date:  2017-05-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.